Azithromycin-Mepha 200, Pulver zur Herstellung einer Suspension zum Einnehmen - 30 ml Swissmedic Key 58081003 Registration Holder Mepha Pharma AG Name Azithromycin-Mepha 200, Pulver zur Herstellung einer Suspension zum Einnehmen Date of registration 25.07.2007 Original/Generic Generic Introduction of Sequence 25.07.2007 ATC-Classification Azithromycin (J01FA10) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.01.60. Show package size 30 ml Index Therapeuticus (Swissmedic) 08.01.60. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 8.93 Limitation No Deductible 10 % Consumer price 26.10 Feedback FB Daily cost GTIN 7680580810034 Medication Code Synthetika Pharmacode 3636069 Disponibility
Composition azithromycinum 200 mg ut azithromycinum dihydricum, saccharum 3712 mg, xanthani gummi, hydroxypropylcellulosum, trinatrii phosphas anhydricus, silica colloidalis anhydrica, aromatica (Vanille, Banane, Kirschen) cum alcohol benzylicus, aspartamum 30 mg, excipiens ad pulverem corresp. suspensio reconstituta 5 ml corresp. natrium 7.744 mg, natrium 7.74 mg. Packungsbestandteile Galenic Form Excipiens Active Agent Dose Azithromycin 200 mg
BAG: Active Agent Dose Azithromycin 200 mg
Inactive agents Dose Aspartame 30 mg Saccharum 3712 mg Silica Colloidalis Anhydrica
Source Data was imported : 07.03.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
